Alvotech 6-K adds 9M 2025 earnings update to key registrations

Rhea-AI Filing Summary

Alvotech submitted a Form 6-K as a foreign private issuer to furnish a recent press release to investors. The filing states that, on November 12, 2025, the company issued a press release announcing its earnings for the first nine months of 2025 and providing a business update. The Form 6-K also clarifies that, except for the attached press release, the report is incorporated by reference into several existing Alvotech shelf and employee share plan registration statements, which means those registrations now formally include this new information.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-41421

Alvotech
(Translation of registrant's name into English)

9, Rue de Bitbourg,
L-1273 Luxembourg,
Grand Duchy of Luxembourg
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

Incorporation by Reference

This Report on Form 6-K (this “Report”) of Alvotech (the “Company”) excluding Exhibit 99.1 attached hereto, shall be deemed to be incorporated by reference into the Company’s registration statements on Forms F-3 (File Nos. 333-266136, 333-273262, 333-275111 and 333-281684), the Company’s registration statement on Form F-3ASR (File No. 333-289006), and the Company’s registration statement on Form S-8 (File No. 333-266881) and to be a part thereof from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. Exhibit 99.1 to this Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Press Releases

On November 12, 2025, Alvotech issued a Press Release announcing its earnings for the first nine months of 2025 and providing a business update. A copy of the Press Release is furnished herewith as exhibit 99.1.

EXHIBIT INDEX

Exhibit Number		Description
99.1		Press Release dated November 12, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Alvotech
		(Registrant)
Date: November 13, 2025		/s/ Tanya Zharov
		Tanya Zharov
		General Counsel

FAQ

What did Alvotech (ALVO) report in this Form 6-K?

Alvotech filed a Form 6-K to furnish a press release that announced its earnings for the first nine months of 2025 and provided a business update.

What is included as Exhibit 99.1 in Alvotech's November 2025 Form 6-K?

Exhibit 99.1 is a press release dated November 12, 2025, in which Alvotech announced earnings for the first nine months of 2025 and shared a business update.

Are parts of this Alvotech (ALVO) Form 6-K incorporated by reference into other registrations?

Yes. The Form 6-K, excluding Exhibit 99.1, is incorporated by reference into Alvotech’s Forms F-3, F-3ASR and Form S-8 registration statements.

Is Alvotech's earnings press release in Exhibit 99.1 considered filed or just furnished?

The press release in Exhibit 99.1 is described as furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings.

Which type of annual report does Alvotech (ALVO) file with the SEC?

Alvotech indicates that it files annual reports under cover of Form 20-F, which is the standard annual report form for foreign private issuers.

Who signed the November 2025 Form 6-K for Alvotech?

The Form 6-K was signed on behalf of Alvotech by Tanya Zharov, who is identified as the company’s General Counsel.